Quarterly report · Q2
3401.TEDINET S100S6J7
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥506.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥1.02T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥510.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥14.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥10.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥9.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥19.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥541m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.6bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥742m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.32T | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.24T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.31T | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥848.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥791.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥472.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥451.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥482.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥155.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥142.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥152.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥140.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥130.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥23.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥55.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥27.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥52.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥29.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥18.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.81 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.46 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-92.04 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.41 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.59 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.34 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 33.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥29.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥27.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | −¥530m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥70.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥70.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥8.2bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥220.5bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥215.5bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥5.3bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥488.3bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥479.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9.3bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥14.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥518.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥506.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥13.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥26.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥24.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥693m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥77.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥77.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥227.7bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥222.6bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥5.8bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥495.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥486.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥9.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥522.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥510.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 566
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 197953707 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 37024000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1923 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 13452000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0698 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 9514000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0494 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 7046000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0365 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 6657000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0345 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 3188000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0165 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 3121000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0162 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 2897000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0150 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 2556000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0132 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 2552000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0132 | |
| Number of shares held | CurrentQuarterInstant | 88006000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4566 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 5443300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 191957600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1919576 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 552807 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 197953707 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 1919576 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 5443300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 5443300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0275 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 5443300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 5443300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0275 | |
| Cash and deposits | Prior1YearInstant | 142780000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 155447000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 186460000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 198019000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 125878000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 146365000000 | JPY |
| Work in process | Prior1YearInstant | 15596000000 | JPY |
| Work in process | CurrentQuarterInstant | 17139000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 55252000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |